These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 11413853)
21. Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia. Lu CL; Lin YH; Wong WW; Lin HH; Ho MW; Wang NC; Hsieh SM; Sheng WH; Hung CC; Chen MY J Microbiol Immunol Infect; 2011 Aug; 44(4):258-64. PubMed ID: 21524961 [TBL] [Abstract][Full Text] [Related]
22. Adverse drug reactions to protease inhibitors. Manchanda T; Schiedel D; Fischer D; Dekaban GA; Rieder MJ Can J Clin Pharmacol; 2002; 9(3):137-46. PubMed ID: 12422251 [TBL] [Abstract][Full Text] [Related]
23. Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment. Penzak SR; Chuck SK Scand J Infect Dis; 2000; 32(2):111-23. PubMed ID: 10826894 [TBL] [Abstract][Full Text] [Related]
24. The effects of HIV protease inhibitors on carbohydrate and lipid metabolism. Lee GA; Rao MN; Grunfeld C Curr HIV/AIDS Rep; 2005 Feb; 2(1):39-50. PubMed ID: 16091248 [TBL] [Abstract][Full Text] [Related]